 |
ambrisentan |
|---|---|
| Trade Name | Letairis |
| Orphan Indication | Pulmonary Arterial Hypertension |
| USA Market Approval | USA |
| USA Designation Date | 2004-07-16 00:00:00 |
| Sponsor | Gilead Colorado;7575 West 103rd Avenue, Suite 102;Westminister, Colorado, 80021 |
| |
ambrisentan |
|---|---|
| Trade Name | Letairis |
| Orphan Indication | Pulmonary Arterial Hypertension |
| USA Market Approval | USA |
| USA Designation Date | 2004-07-16 00:00:00 |
| Sponsor | Gilead Colorado;7575 West 103rd Avenue, Suite 102;Westminister, Colorado, 80021 |